Efficacy and safety evaluation of sucrose-formulated recombinant factor VIII for Taiwanese patients with haemophilia A

Haemophilia

Volumn 15, Issue 4, 2009, Pages 968-970

  Young, Ji Hsiung ^a   Liu, H C ^b   Hsueh, E J ^c   Huang, M L ^d   Peng, C T ^e   Chen, R L ^f   Maas Enriquez, M ^g   Achilles, K ^h  

^a LIN SHIN HOSPITAL   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^d SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHI MEI MEDICAL CENTER   (Taiwan)

^g BAYER PHARMA AG   (Germany)

^h BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 8; SUCROSE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CHILD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HEMOPHILIA A; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; TAIWAN; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COAGULANTS; FACTOR VIII; HEMOPHILIA A; HUMANS; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; SUCROSE; TAIWAN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649878837     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02024.x     Document Type: Article

References (5)

1. Hay CR. The epidemiology of factor VIII inhibitors. Haemophilia 2006; 12: 23-8.
2. Abshire TC, Brackmann HH, Scharrer I et.al. Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy - International Kogenate-FS Study Group. Thromb Haemost 2000; 83: 811-6.
3. Shi J, Zhao Y, Wu J, Sun J, Wang L, Yang R. Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China. Haemophilia 2007; 13: 351-6.
4. Delumeau JC, Ikegawa C, Yokoyama C, Haupt V. An observational study of sucrose-formulated recombinant factor VIII for Japanese patients with haemophilia A. Thromb Haemost 2008; 100: 32-7.
5. Musso R, Santagostino E, Faradji A et.al. Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting. Thromb Haemost 2008; 99: 52-8.